(Updates)
** Shares of diagnostic tests developer Intelligent Bio
Solutions Inc INBS.O fall 46% to $3.19 in morning trade
** Co announces pricing of stock offering of 569,560 common
shares and 170,868 shares in warrant equivalents for initial
gross proceeds of ~$2.2 mln
** Offering price at $3.90/shr represents 34.2% discount to
stock's $5.93 close on Tuesday
** Ladenburg Thalmann & Co Inc is acting as the sole
bookrunning manager for the offering - INBS
** INBS has 916.3k shares outstanding and 844.6k free float
shares - Refinitiv data
** Co had cash and cash equivalents of $2.9 mln as of Dec.
31, 2022
** Stock has declined 84% since co announced key milestones
in its biosensor platform development in Jan
(Reporting by Raghav Mahobe and Aditya Samal)
((Raghav.Mahobe@thomsonreuters.com;))